Jacob Tellgren has been appointed Vice President and Global Brand Leader Diabetes at Merck & Co at MSD’s headquarter in the US.
Tellgren has been CEO of MSD Sweden since Januart 2014 and he is for example responsible for organizing MSD according to the healthcare regions and making the dialogue with the healthcare principals a high priority. He holds a MBA from Uppsala University and has the last 15 years had leading positions within MSD, both nationally and internationally.
“It i important that MSD continues to contribute to the development in healthcare. My ambition during my time as CEO has been to strengthen the collaboration even more with the healthcare sector, the academia, central authorities and departments in order to provide the best possible care to the patients. We have made important progress but much work remain in order to fulfill the ambitions of making Sweden a leading life science nation,” says Jacob Tellgren.
Diabetes is one of MSD’s most important therapy areas and last year’s revenue was six billion USD.
